LTS Lohmann Therapie-Systeme AG, the market leader for the development and manufacturing of transdermal therapeutic systems, is very pleased to announce the appointment of Mr. David Doles as the President and Chief Executive Officer for its US affiliate, LTS Lohmann Therapy Systems, Corp. effective 1 January 2020.
This web seminar shows the characteristics and advantages of TTS [...]
An European Patent for LTS’ application relating to an asenapine transdermal therapeutic system (TTS).
Inspection successfully concluded. In September, the German health authorities extended the manufacturer’s authorisation for LTS Lohmann Therapie-Systeme AG (LTS) to include capsules.
The LTS plant fire brigade donates a decommissioned fire-fighting vehicle to the Zichow fire brigade, whose fire-truck has burnt down during a fire in the engine house in February of this year.
LTS Lohmann Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic systems, and LEO Pharma A/S, a global leader in dermatology, today announced that the companies will start the clinical trial of microarray patches for the local intradermal treatment of psoriasis.
LTS congratulates its business partner Dr. Reddy’s Laboratories Ltd. for the US launch of its Buprenorphine and Naloxone Sublingual Film.
EsoCap AG and LTS Lohmann Therapy-Systeme AG announced the start of cooperation on industrial development of a unique drug delivery technology for diseases of the upper gastrointestinal tract.
In January members of the Association, along with Dr. Torsten Baehner, head physician of the Anaesthesia and IC unit at St. Nikolaus-Stift Hospital, displayed the trolley for Ulrich Sielaff, member of the board at LTS.
This web seminar shows the components and science of OTFs [...]
